Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2020-12-17 20:13:26
Reporting Period:
Accepted Time:
2020-12-17 20:13:26
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1703647 Frequency Therapeutics Inc. FREQ Pharmaceutical Preparations (2834) 472324450
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1785299 R. Christopher Loose C/o Frequency Therapeutics, Inc.
19 Presidential Way, 2Nd Floor
Woburn MA 01801
Chief Scientific Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-12-17 6,000 $40.00 41,782 No 4 S Direct
Common Stock Disposition 2020-12-17 2,000 $42.50 39,782 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 11, 2020.
  2. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $42.5 to $42.52. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.